These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9143023)

  • 1. Immunohistochemical analysis of the nm23 gene products in testicular seminoma.
    Hori K; Uematsu K; Yasoshima H; Sakurai K; Yamada A; Ohya M
    Pathol Int; 1997 May; 47(5):288-92. PubMed ID: 9143023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the metastasis suppressor gene nm23 and the proto-oncogene c-myc in human testicular germ cell tumors.
    Schmidt B; Ackermann R; Hartmann M; Strohmeyer T
    J Urol; 1997 Nov; 158(5):2000-5. PubMed ID: 9334657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma.
    Yamaguchi A; Urano T; Goi T; Takeuchi K; Niimoto S; Nakagawara G; Furukawa K; Shiku H
    Cancer; 1994 May; 73(9):2280-4. PubMed ID: 8168032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.
    Konishi N; Nakaoka S; Tsuzuki T; Matsumoto K; Kitahori Y; Hiasa Y; Urano T; Shiku H
    Jpn J Cancer Res; 1993 Oct; 84(10):1050-4. PubMed ID: 7693635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NM23 gene and its expression in oral squamous cell carcinoma.
    Lo Muzio L; Mignogna MD; Pannone G; Staibano S; Procaccini M; Serpico R; De Rosa G; Scully C
    Oncol Rep; 1999; 6(4):747-51. PubMed ID: 10373649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
    Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
    Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.
    Martinez JA; Prevot S; Nordlinger B; Nguyen TM; Lacarriere Y; Munier A; Lascu I; Vaillant JC; Capeau J; Lacombe ML
    Gut; 1995 Nov; 37(5):712-20. PubMed ID: 8549951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance.
    Aryee DN; Ströbel T; Kos K; Salzer-Kuntschik M; Zoubek A; Veron M; Ambros IM; Traincart F; Gadner H; Kovar H
    Int J Cancer; 1995 Apr; 64(2):104-11. PubMed ID: 7542225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
    Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
    Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
    Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of nm23/NDP kinase proteins on the cell surface.
    Urano T; Furukawa K; Shiku H
    Oncogene; 1993 May; 8(5):1371-6. PubMed ID: 8386830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amplification, clone and identification of the specific fragments of tumor metastasis-suppressor gene nm23-H1 and nm23-H2].
    Li C; Lu Y; Wang R
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 Nov; 15(4):322-4. PubMed ID: 11479979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological study on the expression of cell adhesion molecules and metastasis suppressor gene in thyroid follicular carcinoma and papillary carcinoma].
    Liu Y; Jiang C; Tan Y
    Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):322-6. PubMed ID: 12417089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness.
    Takino H; Herman V; Weiss M; Melmed S
    J Clin Endocrinol Metab; 1995 May; 80(5):1733-8. PubMed ID: 7745027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of nm23/NDP kinase expression in human lung adenocarcinoma: association with tumor progression in Clara cell type.
    Ozeki Y; Takishima K; Mamiya G
    Jpn J Cancer Res; 1994 Aug; 85(8):840-6. PubMed ID: 7928630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of nm23-H1 protein in bladder cancer.
    Kuo JY; Chiang H; Chen KK; Chang LS
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):411-7. PubMed ID: 10418173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
    Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
    Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.
    Dueñas-González A; Abad-Hernández MM; García-Mata J; Paz-Bouza JI; Cruz-Hernández JJ; González-Sarmiento R
    Cancer Lett; 1996 Mar; 101(2):137-42. PubMed ID: 8620461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.